Monoclonal antibody
Type ?
Source Human
Target activin receptor-like kinase 1
Clinical data
ATC code none
CAS Number 1463459-96-2
ChemSpider none
Chemical and physical data
Formula C6396H9850N1694O2012S44
Molar mass 144.1 kg/mol

Ascrinvacumab is a monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by Pfizer Inc.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Ascrinvacumab, American Medical Association.
This article is issued from Wikipedia - version of the 5/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.